Doug leads the MedTech Innovation, Product Development and R&D practice within Deloitte. He has over 30 years of experience in Medical Device innovation, product strategy, product development, operational scale-up and merger integration. He has successfully worked in and with multinational corporations and technology startups to help them successfully conceive, create and commercialize market leading products and solutions. Doug has led several clients through global transformations and scale-up of product development capability across all functions (R&D, Digital Development, Quality, Clinical, Marketing, Regulatory, Manufacturing, Supply Chain and Procurement) resulting in faster and more sustainable realization of growth and profitability objectives. These programs have included the integration of lean, agile, design thinking, concurrent engineering, supplier co-development and other advanced product design, process design and project management methodologies.
His experiences includes working across a variety of medical device markets including diabetes and metabolic disease, general surgery, interventional cardiology, interventional oncology, chronic disease management, emergency medicine and interventional neurology. Doug has a degree in Biology from Duke University and an MBA from Ross School of Business at the University of Michigan.